These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31158272)

  • 1. Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.
    Ludmir EB; Mainwaring W; Lin TA; Miller AB; Jethanandani A; Espinoza AF; Mandel JJ; Lin SH; Smith BD; Smith GL; VanderWalde NA; Minsky BD; Koong AC; Stinchcombe TE; Jagsi R; Gomez DR; Thomas CR; Fuller CD
    JAMA Oncol; 2019 Dec; 5(12):1769-1773. PubMed ID: 31158272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled Analysis.
    Addeo A; Weiss GJ; Gyawali B
    JAMA Netw Open; 2019 May; 2(5):e193684. PubMed ID: 31074821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer Type.
    Jairam V; Yu JB; Aneja S; Wilson LD; Lloyd S
    Am J Clin Oncol; 2017 Jun; 40(3):312-317. PubMed ID: 25374144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials.
    Ludmir EB; Subbiah IM; Mainwaring W; Miller AB; Lin TA; Jethanandani A; Espinoza AF; Mandel JJ; Fang P; Smith BD; Smith GL; Pinnix CC; Sedrak MS; Kimmick GG; Stinchcombe TE; Jagsi R; Thomas CR; Fuller CD; VanderWalde NA
    J Geriatr Oncol; 2020 Apr; 11(3):451-454. PubMed ID: 31711757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current status of clinical trials on cancer and age disparities among the most common cancer trial participants.
    Zhao S; Miao M; Wang Q; Zhao H; Yang H; Wang X
    BMC Cancer; 2024 Jan; 24(1):30. PubMed ID: 38166779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance Status Restriction in Phase III Cancer Clinical Trials.
    Abi Jaoude J; Kouzy R; Mainwaring W; Lin TA; Miller AB; Jethanandani A; Espinoza AF; Pasalic D; Verma V; VanderWalde NA; Smith BD; Smith GL; Fuller CD; Das P; Minsky BD; Rödel C; Fokas E; Jagsi R; Thomas CR; Subbiah IM; Taniguchi CM; Ludmir EB
    J Natl Compr Canc Netw; 2020 Oct; 18(10):1322-1326. PubMed ID: 33022640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Based Disparities Among Cancer Clinical Trial Participants.
    Ludmir EB; Fuller CD; Moningi S; Mainwaring W; Lin TA; Miller AB; Jethanandani A; Espinoza AF; Verma V; Smith BD; Smith GL; VanderWalde NA; Holliday EB; Guadagnolo BA; Stinchcombe TE; Jagsi R; Gomez DR; Minsky BD; Rödel C; Fokas E
    J Natl Cancer Inst; 2020 Feb; 112(2):211-213. PubMed ID: 31350545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and gender disparities in traumatic brain injury clinical trial enrollment.
    Bah MG; Naik A; Barrie U; Dharnipragada R; Eden SV; Arnold PM
    Neurosurg Focus; 2023 Nov; 55(5):E11. PubMed ID: 37913537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities between randomized clinical trial participants and sepsis patients in real-world.
    Bai X; Zeng P; Wang B; Zhang Z; Jin X; Kang Y; Cheng Y; Wu Q
    J Crit Care; 2023 Oct; 77():154362. PubMed ID: 37413841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials.
    Patel RR; Parisi R; Verma V; Kouzy R; Abi Jaoude J; Lin TA; Fuller CD; VanderWalde NA; Jagsi R; Smith BD; Guadagnolo BA; Thomas CR; Ludmir EB
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of contemporary atrial fibrillation clinical trials and their association with industry sponsorship.
    Lan RH; Paranjpe I; Saeed M; Perez MV
    Heart Rhythm; 2024 Sep; 21(9):1517-1523. PubMed ID: 38453036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
    Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I
    Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation.
    Fundytus A; Wells JC; Sharma S; Hopman WM; Del Paggio JC; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
    Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):28-35. PubMed ID: 34479769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research.
    Sherry AD; Corrigan KL; Kouzy R; Jaoude JA; Yang Y; Patel RR; Totten DJ; Newman NB; Das P; Taniguchi C; Minsky B; Snyder RA; Fuller CD; Ludmir E
    Cancer; 2023 Nov; 129(21):3430-3438. PubMed ID: 37382235
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.